Myeloid/natural killer cell precursor acute leukemia (MNKPL) is a rare leukemia subtype characterized by a high incidence of extramedullary infiltration. No appropriate treatment strategy has so far been developed. Acute myelogenous leukemia-type chemotherapy combined with L-Asparaginase is an effective treatment for MNKPL. Hematopoietic cell transplantation is a second option in refractory cases.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986054 | PMC |
| http://dx.doi.org/10.1002/ccr3.1506 | DOI Listing |
Publication Analysis
Top Keywords
hematopoietic cell
8
cell transplantation
8
cell precursor
8
precursor acute
8
acute leukemia
8
transplantation myeloid/nk
4
myeloid/nk cell
4
leukemia second
4
second remission
4
remission myeloid/natural
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!